Active Supportive Care and Symptom Management Grants

PI Namesort descending Organization - Company Title Major Program / Research Group FOA
Armenian, Saro Beckman Research Institute/City Of Hope Reducing risk of Anthracycline-related heart failure after childhood cancer Community Oncology and Prevention Trials, Cardiotoxicity PA-13-302
CHOW, ERIC JESSEN FRED HUTCHINSON CANCER RESEARCH CENTER Improving treatment of cardiovascular risk factors in childhood cancer survivors Cardiotoxicity PA-13-302
CHOW, ERIC JESSEN FRED HUTCHINSON CANCER RESEARCH CENTER Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy Cardiotoxicity PA-13-302
Herrmann, Joerg Mayo Clinic Rochester TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial Community Oncology and Prevention Trials, Cardiotoxicity PA-18-003
KWAN, MARILYN L KAISER FOUNDATION RESEARCH INSTITUTE Predictors of CVD among breast cancer survivors in an integrated health system Cardiotoxicity PA-16-035
Yeh, Jennifer M. Boston Children'S Hospital Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future Community Oncology and Prevention Trials, Cardiotoxicity, Pediatrics/Adolescents/Young Adult PAR-16-218